Literature DB >> 15345509

Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy.

Spencer D Proctor1, Donna F Vine, John C L Mamo.   

Abstract

OBJECTIVES: There is accumulating evidence that an increased risk of cardiovascular disease (CVD) is not simply caused by the degree of arterial exposure to plasma lipoproteins but, in addition, is determined by the affinity of the vasculature for different lipoprotein phenotypes. In this study we compare the delivery and efflux of 2 atherogenic lipoproteins to further understand the factors that regulate cholesterol accumulation in early atherogenesis. METHODS AND
RESULTS: Lipoproteins containing apolipoprotein (apo) B100 (a low-density lipoprotein [LDL]) and apoB48 (chylomicron remnants) were isolated and differentially conjugated with fluorophores and simultaneously perfused at equivalent concentrations in situ through rabbit carotid vessels. Perfusion systems were established to quantify and differentiate between lipoprotein arterial delivery and efflux. The total average rate of delivery for LDL particles (23 nm) compared with chylomicron remnants (50 nm) was 4427 particles/min(-1) per microm3 and 452 particles/min(-1) per microm3, respectively. In contrast, the average rate of efflux was 3195 particles/min(-1) per microm3 and 163 particles/min(-1) per microm3 for LDL and chylomicron remnants, respectively.
CONCLUSIONS: Results indicate that although LDL particles have a higher rate of delivery, they efflux more readily from arterial tissue compared with the larger chylomicron remnants. Collectively, our findings highlight that lipoproteins permeate through arterial tissue differently and may be dependent on the phenotype and potential interactions with extracellular matrix components.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345509     DOI: 10.1161/01.ATV.0000143859.75035.5a

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  22 in total

1.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

2.  Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.

Authors:  Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-04-04       Impact factor: 1.880

Review 3.  Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.

Authors:  Lisa R Tannock; Victoria L King
Journal:  Rev Endocr Metab Disord       Date:  2008-06-27       Impact factor: 6.514

4.  Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats.

Authors:  J C Russell; S E Kelly; D F Vine; S D Proctor
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

5.  Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.

Authors:  Ann-Trude With Notø; Ellisiv Bøgeberg Mathiesen; Jan Brox; Johan Björkegren; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-03-05       Impact factor: 1.880

6.  Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases.

Authors:  Boudewijn Klop; Spencer D Proctor; John C Mamo; Kathleen M Botham; Manuel Castro Cabezas
Journal:  Int J Vasc Med       Date:  2011-09-25

7.  Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults.

Authors:  Krista A Varady; Surabhi Bhutani; Monica C Klempel; Cynthia M Kroeger
Journal:  Lipids Health Dis       Date:  2011-07-18       Impact factor: 3.876

8.  The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis.

Authors:  John-Bjarne Hansen; José A Fernández; Ann-Trude With Notø; Hiroshi Deguchi; Johan Björkegren; Ellisiv B Mathiesen
Journal:  J Lipids       Date:  2011-07-06

Review 9.  Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins.

Authors:  Sameer Ansar; Juraj Koska; Peter D Reaven
Journal:  Cardiovasc Diabetol       Date:  2011-07-07       Impact factor: 9.951

10.  Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat.

Authors:  Rabban Mangat; Samantha Warnakula; Faye Borthwick; Zahra Hassanali; Richard R E Uwiera; James C Russell; Christopher I Cheeseman; Donna F Vine; Spencer D Proctor
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.